Krabi Cannabis Farm Closed After Hidden Foreign Investors and High THC

The Thailand Department of Business Development (DBD) has ordered an immediate shutdown of a high-tech cannabis farm in Krabi, a move that signals the government’s intent to tighten nominee-shareholding loopholes before new medical-only rules take effect.

Why This Matters

• 60-day license suspension starts this week; a permanent revocation is on the table if paperwork is not fixed.

• Nominee crackdowns are widening—DBD says more than 120,000 mixed-ownership companies will be screened in 2026.

• THC above 0.2 % remains classified as a narcotic; possession outside a medical setting risks up to 5 years in jail.

Inside the Krabi Operation

Officials from the Krabi Provincial Police, Public Health Office, and DBD walked into an air-conditioned warehouse lined with Israeli-designed grow lights, drip-feed irrigation, and climate sensors—technology that until recently was touted as the gold standard for pharmaceutical-grade cultivation. An Israeli entrepreneur, whose investment highlights Israel’s reputation for agri-tech innovation, was present while officers catalogued flowering plants and processing equipment.

Laboratory tests confirmed THC levels exceeding the legal 0.2 % threshold, automatically moving the crop into the narcotic category and triggering an administrative suspension. Separately, business-registration checks showed the shareholding structure had shifted from 100 % Thai to majority foreign within eight months, a pattern regulators call grey capital.

Grey Capital vs. Foreign Business Act

Under the Foreign Business Act B.E. 2542, foreign investors may own no more than 49 % of entities in Thailand’s controlled-herb sector unless a special licence is granted. Using Thai nationals as stand-in shareholders—known locally as nominee arrangements—carries penalties of up to 3 years in prison and a ฿1 M fine. Four Thai nominees linked to the Krabi farm have already been summoned.

How the Rules Keep Shifting

June 2025: Ministry of Public Health re-classified cannabis flowers as a controlled herb, limiting retail to pharmacies and registered Thai Traditional Medicine clinics.

August 2025: 7,000+ recreational shops were told to convert to medical models or close.

January 2026: DBD began cross-checking shareholder lists with immigration and tax databases to detect beneficial-ownership mismatches.

What This Means for Residents

• Tourists & consumers: Expect fewer casual dispensaries. Possessing flower with >0.2 % THC without a doctor’s note can now lead to arrest.

• Small farmers: The Medical-Plant Permit (MPP) remains available, but at least 2 in 3 directors must be Thai. Keep receipts for seed sourcing and lab tests.

• Expats & investors: Legal counsel now recommends applying for a Foreign Business Licence upfront rather than relying on questionable share structures.

Expert View

"Thailand’s cannabis pivot is not a policy U-turn—it is a housekeeping exercise," said Dr. Kanchana Veerasak, a regulatory-risk analyst in Bangkok. "Foreign innovation, including Israeli cultivation know-how, is still welcome, but only within transparent ownership frameworks."

What Comes Next

The Krabi facility is allowed to petition for reinstatement after the 60-day suspension, provided it brings THC levels down to medical-grade and files an amended shareholder list. Meanwhile, the DBD has hinted at surprise audits in Chiang Mai, Phuket, and Bangkok throughout the first quarter.

Businesses determined to stay in the game should prepare third-party lab certificates, proof of Thai majority control, and on-site medical staff—the paperwork trio inspectors have zeroed in on for 2026.